Science Explorer Back to mapMap
Discussion
Researcher · Favaloro Foundation · Argentina

Zulema Gutfraind

Zulema Gutfraind publishes mostly in Epidemiology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, on topics such as Bacterial Identification and Susceptibility Testing, T-cell and Retrovirus Studies and Antibiotic Use and Resistance.

OpenAlex
World rank
#6,651,903
of 7,710,434 ranked researchers
Rank in Argentina
#28,476
of 38,473
Works
20
Citations
43
Citations per work
2.2
h-index
4
i10-index 1Top 92% in Epidemiology
Zulema Gutfraind

What does Zulema Gutfraind research?

Zulema Gutfraind's work is mostly in Medicine (43%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (9%).

Health Sciences: 9 works · 42.9% of their workMedicine: 9 works · 42.9% of their workEpidemiology: 3 works · 14.3% of their workPulmonary and Respiratory Medicine: 2 works · 11.4% of their workCardiology and Cardiovascular Medicine: 2 works · 8.6% of their workSurgery: 2 works · 8.6% of their workEverything else: 8 works · 39.9% of their workLife Sciences: 3 works · 17.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 8.6% of their workClinical Biochemistry: 2 works · 8.6% of their workImmunology and Microbiology: 2 works · 8.6% of their workImmunology: 2 works · 8.6% of their workTHEIR WORKZulema Gutfraind20works
Life Sciences17%Health Sciences43%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine942.9%
  2. Everything else839.9%
    1. Biochemistry, Genetics and Molecular Biology28.6%
    2. Immunology and Microbiology28.6%
  1. 1Epidemiology14% of their works
  2. 2Pulmonary and Respiratory Medicine11% of their works
  3. 3Cardiology and Cardiovascular Medicine9% of their works
  4. 4Immunology9% of their works
  5. 5Surgery9% of their works
  6. 6Clinical Biochemistry9% of their works

Research topics

Which keywords describe Zulema Gutfraind's research?

The keywords of their largest research topics: Epidemiology, Infection, Immunotherapy, Myocardial Infarction, HTLV-1, Leukemia, Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Microorganism Identification.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Epidemiology84 topics
  2. Infection52 topics
  3. Immunotherapy42 topics
  4. Myocardial Infarction42 topics
  5. HTLV-131 topic
  6. Leukemia31 topic
  7. Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry31 topic
  8. Microorganism Identification31 topic
  9. Acute Coronary Syndromes21 topic
  10. Antibiotic Resistance21 topic
  11. Antimicrobial Stewardship21 topic
  12. Cardiac Imaging21 topic
  13. Coronary Artery Disease21 topic
  14. ST-Segment Elevation21 topic
  15. Sepsis21 topic
  16. Septic Shock21 topic
  17. Bacterial Therapy11 topic
  18. Corynebacterium11 topic
  19. Infections11 topic
  20. Tumor Targeting11 topic

Where does Zulema Gutfraind work?

Zulema Gutfraind's main affiliation in the publication record is Favaloro Foundation, Argentina.

How many publications and citations does Zulema Gutfraind have?

OpenAlex counts 20 works and 43 citations for Zulema Gutfraind, an h-index of 4, ranking #6,651,903 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Zulema Gutfraind. Posts are plain text and can be reported.